Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965302 · ClinicalTrials.gov registry record · NA
Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients
A NA study, sponsored by 59th Medical Wing.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00965302 is a NA study that was terminated before completion, run by 59th Medical Wing. The registered enrollment target is 50 participants.
The verdict
NCT00965302, a NA study, was terminated before completion, sponsored by 59th Medical Wing.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators plan to randomize mild to moderately obese (BMI 30-34.9) subjects to medical management (diet, exercise, and best medical therapy) versus sleeve gastrectomy with medical management, with a primary endpoint of diabetes remission (normal fasting glucose, off medications and insulin) at one year. Sleeve gastrectomy (also called greater curvature gastrectomy, vertical sleeve gastrectomy, and sleeve gastroplasty) involves stapled resection of the gastric fundus. Secondary endpoints include weight loss, improvement in hypertension, sleep apnea, c-reactive protein, and fasting lipid profile.
Interventions
- PROCEDURE Laparoscopic sleeve gastrectomy
- BEHAVIORAL Intensive medical management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00965302
The ClinicalTrials.gov registry entry for NCT00965302 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laparoscopic sleeve gastrectomy is the first listed.
NCT00965302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00965302 about?
NCT00965302 is a clinical study titled "Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients". The investigators plan to randomize mild to moderately obese (BMI 30-34.9) subjects to medical management (diet, exercise, and best medical therapy) versus sleeve gastrectomy with medical management, with a primary endpoint of diabetes remission (normal fasting glucose, off medications and insulin) ...
What is the current status of trial NCT00965302?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2009-08. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00965302?
The interventions under investigation include: Laparoscopic sleeve gastrectomy (PROCEDURE), Intensive medical management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00965302?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.